Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

77 search results for ‘*’


Subspecialties Oncology

Beating the Biopsy

| Michael Schubert

A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment


Diagnostics Precision medicine

Deep Bio’s Deep Dive

| Sponsored by Deep Bio

AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target

Subspecialties Microbiology and immunology

A Whole New (Microbial) World

| Luke Turner

New research uncovers thousands of previously unidentified tiny proteins in the microbiome that could advance our understanding of human health

Diagnostics Histology

Case of the Month

Case of the Month is back for November – but can you diagnose this 1.5 cm polypoid mass shown by ureteroscopy?

Inside the Lab Laboratory management

The Value of One

| Michael Schubert

It’s easy to underestimate the importance of a single laboratory task or a single person – but to do so is a mistake

Inside the Lab Digital and computational pathology

A Renal Revolution

| Michael Schubert

Two new computational pathology tools offer promise in the challenging arena of renal pathology

Diagnostics Genetics and epigenetics

Reference Genome Refresh

| Luke Turner

An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating

Diagnostics Genetics and epigenetics

Unraveling Complexity

| Michael Schubert

A new kind of deep learning model uses nonlinear information to draw new associations between genes and diseases

Diagnostics Genetics and epigenetics

A Pharmacogenomic Promise

| Michael Schubert

Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers

Subspecialties Cytology

A Better Future for Bladder Cancer

| John Cucci

A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register